May 18, 2018 / 8:49 AM / 5 months ago

BRIEF-AstraZeneca CEO Says Drug Industry Needs Clarity On Regulation After Brexit

May 18 (Reuters) - AstraZeneca PLC Pascal Soriot tells reporters:

* CEO SAYS STILL DON’T KNOW WHETHER WILL BE MUTUAL RECOGNITION FOR DRUG REGULATION AFTER BREXIT AND INDUSTRY NEEDS CLARITY Further company coverage: (Reporting by UK bureau)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below